Master in Public Health, Pharmaceutical Biotechnology and Clinical Development
The Master program in Public Health, Pharmaceutical Biotechnology, and Clinical Development is an internationally recognized Executive Master program offered by the University of Siena, Italy in connection with Incheon National University in South Korea, and the International Vaccine Institute.
This innovative program is an extension of the Master in Vaccinology, exploring the unique partnership between biotechnology research and clinical development. Graduates are prepared to be leaders in both the practical and professional aspects of global health, equipped with the knowledge and skills to apply cutting-edge technologies to the discovery, assessment, development, and production of clinical pharmaceuticals. Graduates also develop a firm understanding of associated global biotechnology regulations so they can make significant contributions to the control of infectious and non-infectious diseases.
The international scope of this program connects graduates with faculty members, industry leaders, and professionals from around the world. This network empowers graduates to transform the face of global health on a truly global scale and make an impact in any number of international communities at home or abroad.
Entry into this program is open to biotech industry professionals, suppliers, and regulatory entities. A university degree in medicine is not required.
Program duration: 12 months
- 5 modules
Modules 1, 3, and 4 are held at the University of Siena, Italy.
Modules 2 and 5 and the thesis defense are held at Incheon National University, South Korea.
Subscribe to our newsletter and receive the latest news about the Institute for Global Health.